Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Polyposis, Gastric 1Oropharyngeal Neoplasms 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Anus Neoplasms 1Acute Upper Gastrointestinal Bleeding 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 76Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomach Neoplasms × Epinephrine × Gastrointestinal × Clear all
NCT04032119 2025-05-04

RCT of Gastric ESD With or Without Epineprhine Added Solution

Chinese University of Hong Kong

Phase 3 Completed
800 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05688020 2023-08-09

Tranexamic Acid During Upper GI Endoscopic Resection Procedures

Assaf-Harofeh Medical Center

Phase 4 Unknown
200 enrolled
Gastrointestinal

Polyposis, Gastric, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡